Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TusPark is a China-origin science park, incubation, and technology services platform affiliated historically with Tsinghua University and operated through the broader Tus-Holdings/TUS ecosystem. The organization develops and operates science parks, incubators, and cross-border innovation hubs, while also making venture and private equity investments across sectors including life sciences, healthcare, digital technology, and clean energy. In the UK, TusPark operates innovation campuses in Cambridge and Newcastle and promotes its integrated model of incubation, investment, and industry development. Although TusPark has exposure to healthcare and biotech through its investment activities and tenant ecosystem, it is not itself a drug-development or biopharmaceutical company. For a biotech analyst, the most relevant framing is that TusPark is an innovation infrastructure and investment platform that can back or host life science companies rather than a therapeutics developer with an internal clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TusPark.